Urinary excretion of free and acetylated polyamines in hepatocellular carcinoma

International Journal of Biological Markers

Volumn 13, Issue 2, 1998, Pages 92-97

  Antoniello, S ^a   Auletta, M ^a   Magri, P ^a   Pardo, F ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Hepatocellular carcinoma (HCC); Human carcinogenesis; Liver cirrhosis; N1 N8 acetyl spermidine ratio; Tumor markers

Indexed keywords

POLYAMINE; PUTRESCINE; REAGENT; SPERMIDINE; SPERMINE;

ACETYLATION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FILTER; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; POLYAMINE METABOLISM; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; URINARY EXCRETION;

EID: 0031768534     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460089801300205     Document Type: Article

References (31)

1. Pegg AE, McCann PP. Polyamine metabolism and function. Am J Physiol 1982; 243: C212-21.
2. Pegg AE. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 1986; 234: 249-62.
3. Russel DH, Durie BGM. Polyamines as biochemical markers of normal and neoplastic growth. New York: Raven Press, 1978.
4. Okuzumi J, Yamane T, Kitao Y, et al. Increased mucosal ornithine decarboxylase activity in human gastric cancer. Cancer Res 1991; 51: 1448-51.
5. Radford DM, Nakai H, Eddy RL, et al. Two chromosomal locations for human ornithine decarboxylase gene sequences and elevated expression in colorectal neoplasia. Cancer Res 1990; 50: 6146-53.
6. Romano M, Santacroce MA, Bonelli P, Cecco L, Cerra M. Differences in polyamine metabolism between carcinomatous and uninvolved human breast tissues. Int J Biol Markers 1986; 1: 77-80.
7. Braverman DZ, Stankiewicz H, Goldstein R, Patz JK, Morali GA, Jacobson WZ. Ornithine decarboxylase: an unreliable marker for the identification of population groups at risk for colonic neoplasia. Am J Gastroenterol 1990; 85: 723-6.
8. McGarrity TJ, Peiffer LP, Bartholemy MJ, Pegg AE. Colonic polyamine content and ornithine decarboxylase activity as markers for adenomas. Cancer 1990; 66: 1539-43.
9. Romano M, Cecco L, Cerra M. Levels of polyamines and nucleic acids in human breast carcinoma. Tumori 1981; 67: 431-5.
10. Tsuji M, Nakajima T, Sano I. Putrescine, sperimidine, N-acetylspermidine and spermine in the urine of cancer patients with leukemias and tumors. Clin Chim Acta 1975; 59: 161-7.
11. Löser C, Fölsch UR, Paprotny C, Creutzfeldt W. Polyamines in colorectal cancer. Cancer 1990; 65: 958-66.
12. Umeki S, Umeki Y, Okumoto T, Matsumori T. Urinary polyamines in malignancies. Med Lab Sci 1988; 45: 250-4.
13. Lawton F, Griffin M, Slack J, Blackledge G. Urinary polyamine excretion patterns in patients wih epithelial ovarian cancer. Gynecol Obstet Invest 1989; 28: 212-4.
14. Durie BGM, Salmon SE, Russell DH. Polyamines as markers of response and disease activity in cancer chemotherapy. Cancer Res 1977; 37: 214-21.
15. Romano M, Cecco L, Cerra M, De Matteis A. Polyamine excretion as prognostic marker in radiologic therapy of breast carcinoma in metastatic phase. In: Bachrach U, Kaye A, Chayen R, eds. Advances in polyamine research. New York: Raven Press, 1983; 59-64.
16. Kubota S, Yoshimoto M, Yamasaki Z, et al. Urinary polyamines as a tumor marker. Cancer Detect Prev 1985; 8: 189-92.
17. Tamori A, Nishiguchi S, Kuroki T, et al. Relationship of ornithine decarboxylase activity and histological findings in human hepatocellular carcinoma. Hepatology 1994; 20: 1179-86.
18. Bolkenius FN, Seiler N. Acetyl derivatives as intermediates in polyamine catabolism. Int J Biochem 1981; 13: 287-92.
19. Bolkenius FN, Bey P, Seiler N. Specific inhibition of polyamine oxidase in vivo is a method for elucidation of its physiological role. Biochim Biophys Acta 1985; 838: 69-76.
20. Oka H, Kurioka N, Kim K, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 680-7.
21. Colombo M, De Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991; 325: 675-80.
22. Child CG, Turcotte JC. Surgery and portal hypertension. In: Child CG, ed. The liver and portal hypertension. Philadelphia: W.B. Saunders Co. 1964; 1-85.
23. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transaction of the oesophagus for bleeding oesophageal varices. Br J Surgery 1973; 60: 646-9.
24. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998; 27: 273-8.
25. Japan Liver Cancer Study Group 1983, Kanahara Co, Tokyo.
26. Owen JA, Iggo B, Scandrett FJ, Steward CP. The determination of creatinine in plasma or serum and urine. A critical examination. Biochem J 1954; 58: 426-37.
27. Cecco L, Antoniello S, Auletta M, Cerra M, Bonelli P. Pattern and concentration of free and acetylated polyamines in urine of cirrhotic patients. Intern J Biol Markers 1992; 7: 52-8.
28. Matsui-Yuasa I, Obayashi M, Hasuma T, Otani S. Enhancement of spermidine/sperimine N1-acetyltransferase activity by treatment with lithium chloride in Ehrlich ascites tumor cells. Chem Biol Interact 1992; 81: 233-42.
29. Russell DH, Snyder SH, Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chicken embryo and various tumors. Proc Natl Acad Sci USA 1968; 60: 1420-7.
30. Luk GD. Essential role of polyamine metabolism in hepatic regeneration. Gastroenterology 1986; 90: 1261-7.
31. Auvinen M, Paasinen A, Anderson LC, Holtta E. Ornithine decarboxylase activity is critical for cell transformation. Nature 1992; 360: 355-8.